Guidant Rethinks Everolimus-Eluting Stent Platform Strategy, Timeframes
This article was originally published in The Gray Sheet
Executive Summary
Guidant acknowledges that its initial drug-eluting stent may have to be a cobalt-chromium, durable-polymer stent if design changes to the bioabsorbable-polymer Champion require renewed preclinical or clinical testing